A

Avenue Therapeutics
D

ATXI

2.01000
USD
-0.02
(-0.99%)
مغلق
حجم التداول
748
الربح لكل سهم
-20
العائد الربحي
-
P/E
0
حجم السوق
3,842,382
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    G
    GLYC
    0.02000
    (4.95%)
    0.42420 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    K
    KPTI
    -0.02960
    (-3.54%)
    0.80740 USD
    M
    MGNX
    -0.23000
    (-6.04%)
    3.58000 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    U
    UTHR
    -22.88
    (-5.92%)
    363.44 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Avenue Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.